These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8831876)

  • 21. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
    Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
    Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation and stroke prevention.
    Lip GY; Lim HS
    Lancet Neurol; 2007 Nov; 6(11):981-93. PubMed ID: 17945152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implication of antiembolic trials in atrial fibrillation and role of transesophageal echocardiography in atrial fibrillation.
    Jagasia DH; Williams B; Ezekowitz MD
    Curr Opin Cardiol; 2000 Jan; 15(1):58-63. PubMed ID: 10666662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation.
    Kan BD; Katz DA
    JAMA; 1996 Mar; 275(12):909; author reply 910. PubMed ID: 8598612
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation].
    Scheen AJ
    Rev Med Liege; 1999 Jun; 54(6):561-3. PubMed ID: 10446529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention in nonvalvular atrial fibrillation.
    Albers GW; Atwood JE; Hirsh J; Sherman DG; Hughes RA; Connolly SJ
    Ann Intern Med; 1991 Nov; 115(9):727-36. PubMed ID: 1834004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.
    Fitzgerald BT; Cohn SL; Klein AL
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S24-30. PubMed ID: 15853176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.
    Smith NL; Psaty BM; Furberg CD; White R; Lima JA; Newman AB; Manolio TA
    Arch Intern Med; 1999 Jul; 159(14):1574-8. PubMed ID: 10421280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin vs aspirin and AFASAK 2.
    Bloom JM
    Arch Intern Med; 1999 May; 159(9):1010-1. PubMed ID: 10326947
    [No Abstract]   [Full Text] [Related]  

  • 33. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.
    Gurwitz JH; Monette J; Rochon PA; Eckler MA; Avorn J
    Arch Intern Med; 1997 May; 157(9):978-84. PubMed ID: 9140268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing stroke in patients with nonrheumatic atrial fibrillation.
    Nelson KM; Talbert RL
    Am J Hosp Pharm; 1994 May; 51(9):1175-83. PubMed ID: 8042636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).
    Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL;
    Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database.
    Majeed A; Moser K; Carroll K
    Heart; 2001 Sep; 86(3):284-8. PubMed ID: 11514479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and management of atrial fibrillation in primary care: a case study.
    Khan MA; Raja S; Ibrahim MS; Hammersely C
    Prim Health Care Res Dev; 2014 Oct; 15(4):355-61. PubMed ID: 24451067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin and prevention of stroke.
    Morocutti C; Coccheri S
    Lancet; 1994 Jan; 343(8891):234. PubMed ID: 7904685
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antithrombotic therapy of atrial fibrillation].
    Chalon S; Lechat P
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1533-42. PubMed ID: 9092415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.